placeholder image

Brian P. Casserly Adjunct Assistant Professor of Medicine

Brown Affiliations

scholarly work

9. Casserly B, Read R and Levy MM. Hemodynamic monitoring in sepsis. Clinics in Critical Care. (in press)

8. Casserly B, Klinger J. Brain Natriuretic Peptide (BNP) in pulmonary arterial hypertension and its therapeutic potential. Drug Design, Development and Therapy. (in press)

patient following the institution of Infliximab. Lung. 2009 May-Jun;187(3):149-52

hypertension. Drug Design, Development and Therapy. 2008:2 265–280. 265.

4. Rounds S, Lu Q, Harrington EO, Newton J, Casserly B. Pulmonary Endothelial Cell Signaling and Function. Trans Am Clin Climatol Assoc. 2008; 119: 155–169

5. Ward N, Casserly B, Ayala A. The compensatory anti-inflammatory response. Clinics in Chest Medicine Clin Chest Med. 2008 Dec;29(4):617-25, viii. .

3. Klinger J, Murray J, Casserly B, Alvarez D, King J, An S, Choudhary G, Owusu-Sarfo A, Warburton R, Harrington E. Rottlerin causes Pulmonary Edema in vivo: A Possible Role for PKCdelta. J of Appl Phys. 2007 Dec;103(6):2084-94..

2. Sanchez T, Skoura A, Wu MT, Casserly B, Harrington EO, Hla T. Intrduction of Vascular Permeability by the Sphingosine-1-Phosphate Receptor-2 (S1P2R) and its Downstream Effectors ROCK and PTEN. Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1312-8.

1. Casserly B, O'Mahony E, Timm EG, Haqqie S, Eisele G, Urizar R. Propofol Infusion syndrome: an unusual cause of renal failure. Am J Kidney Dis. 2004 Dec;44(6):e98-101.

7. Casserly B, Donat W. Stabilisation of FEV1 and clinical symptoms in a cystic fibrosis

6. Casserly B, Klinger J. Ambrisentan in the management of pulmonary arterial